Literature DB >> 14987392

The role of Raf kinases in malignant transformation.

Walter Kolch1, Ashwin Kotwaliwale, Keith Vass, Petra Janosch.   

Abstract

The Raf kinases are proto-oncogenes that work at the entry point of the mitogen-activated protein kinase/extracellular-signal-regulated kinase (MAPK/ERK) pathway, a signalling module that connects cell-surface receptors and Ras proteins to nuclear transcription factors. The pathway impinges on all the functional hallmarks of cancer cells: immortalisation, growth-factor-independent proliferation, insensitivity to growth-inhibitory signals, ability to invade and metastasise, ability to attract blood vessels, and evasion of apoptosis. Indeed, the pathway is hyperactivated in 30% of all human tumours including prevalent cancers of the colon and lung. The molecular mechanisms underlying the role of Raf kinase in tumourigenesis and the opportunities for therapeutic intervention are reviewed in this article.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14987392     DOI: 10.1017/S1462399402004386

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  21 in total

1.  Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma.

Authors:  Min Zheng; Huijuan Xu; Xin-Hua Liao; Champ Peng Chen; Arina Li Zhang; Wenxian Lu; Long Wang; Dayun Yang; Jichuang Wang; Hekun Liu; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Oncotarget       Date:  2017-05-02

2.  Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI.

Authors:  Mohadeseh Dastpeyman; Nasrin Motamed; Kayhan Azadmanesh; Ehsan Mostafavi; Vahid Kia; Ali Jahanian-Najafabadi; Mohammad Ali Shokrgozar
Journal:  Med Oncol       Date:  2011-11-19       Impact factor: 3.064

3.  Structural modifications of (Z)-3-(2-aminoethyl)-5-(4-ethoxybenzylidene)thiazolidine-2,4-dione that improve selectivity for inhibiting the proliferation of melanoma cells containing active ERK signaling.

Authors:  Kwan-Young Jung; Ramin Samadani; Jay Chauhan; Kerrick Nevels; Jeremy L Yap; Jun Zhang; Shilpa Worlikar; Maryanna E Lanning; Lijia Chen; Mary Ensey; Sagar Shukla; Rosene Salmo; Geoffrey Heinzl; Caryn Gordon; Troy Dukes; Alexander D MacKerell; Paul Shapiro; Steven Fletcher
Journal:  Org Biomol Chem       Date:  2013-06-14       Impact factor: 3.876

4.  Pharmacokinetic interaction involving sorafenib and the calcium-channel blocker felodipine in a patient with hepatocellular carcinoma.

Authors:  Charline Gomo; Romain Coriat; Lionel Faivre; Olivier Mir; Stanislas Ropert; Bertrand Billemont; Alain Dauphin; Michel Tod; Francois Goldwasser; Benoit Blanchet
Journal:  Invest New Drugs       Date:  2010-08-13       Impact factor: 3.850

5.  Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.

Authors:  Mitchell Cheung; Arati Sharma; SubbaRao V Madhunapantula; Gavin P Robertson
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

6.  Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatment.

Authors:  Nunzio Antonio Cacciola; Romina Sepe; Floriana Forzati; Antonella Federico; Simona Pellecchia; Umberto Malapelle; Alfonso De Stefano; Danilo Rocco; Alfredo Fusco; Pierlorenzo Pallante
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-07-28       Impact factor: 3.000

Review 7.  Targeting prostate cancer based on signal transduction and cell cycle pathways.

Authors:  John T Lee; Brian D Lehmann; David M Terrian; William H Chappell; Franca Stivala; Massimo Libra; Alberto M Martelli; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2008-06-16       Impact factor: 4.534

8.  A small molecule disruptor of Rb/Raf-1 interaction inhibits cell proliferation, angiogenesis, and growth of human tumor xenografts in nude mice.

Authors:  Rebecca Kinkade; Piyali Dasgupta; Adam Carie; Daniele Pernazza; Melanie Carless; Smitha Pillai; Nicholas Lawrence; Said M Sebti; Srikumar Chellappan
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

Review 9.  Raf kinases: function, regulation and role in human cancer.

Authors:  Deborah T Leicht; Vitaly Balan; Alexander Kaplun; Vinita Singh-Gupta; Ludmila Kaplun; Melissa Dobson; Guri Tzivion
Journal:  Biochim Biophys Acta       Date:  2007-05-22

Review 10.  Development of extracellular signal-regulated kinase inhibitors.

Authors:  Kimberly Burkhard; Sarice Smith; Rahul Deshmukh; Alexander D MacKerell; Paul Shapiro
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.